Anti-P2Y2

貨號 Cat. No.
APR-010
規格 Size
50 μl 0.2ml

Description

Anti-P2Y2












Product#: APR-010



























Sizes:
50 ml
0.2 ml
 
 
 
 


















Host:
Rabbit.







 










Epitope:

Peptide (C)KPAY GTTGL PRAKR KSVR, corresponding to residues 227-244 of rat P2Y2. (Accession


P41232).







 










Putative epitope location:

3rd intracellular loop (i3) between TM5 and TM6 domains.










 







 










Homology:

Mouse - 18/19 residues identical; human - 17/19 residues identical.









 










Reactivity Confirmed:
Rat.







 

Applications:










Western Blotting:
 









Western blotting of rat brain (1,3) or lung (2,4) membranes.


1,2. Anti-P2Y2 antibody, 1:200

3,4. Anti-P2Y2 antibody, preincubated with the control peptide antigen.









 









References:























1. Wang, L. et al. (2002) J. Cardiovas. Pharmacol. 40, 841.
2. Queiroz, G. et al. (2003) J. Pharmacol. Exp. Ther. 307, 809.
3. Ralevic, V. and Burnstock, G. (1998) Pharmacol. Rev. 50, 413.
4. Abbracchio, M.P. et al. (2003) Trends. Pharmacol. Sci. 24, 52.
5. Di Virgilio, F. et al. (2001) Blood 97, 587.
6. Yerxa, B.R. et al. (2002) J. Pharmacol. Exp. Ther. 302, 871.


The P2Y receptors belong to the G-protein coupled receptors superfamily.  P2Y receptors mediate the actions of the extracellular nucleotides (ATP, ADP, UTP and UDP) and regulate several physiological responses, among them, cardiac function, platelet aggregation and SMC proliferation.1

The mammalian P2Y family currently includes eight functional receptors; P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and the UDP-glucose receptor, now renamed P2Y14 .2-4

P2Y2 receptor is abundantly expressed in the apical membranes of several epithelial tissues including airway.5


P2Y2 receptor has become a leading candidate for the treatment of cystic fibrosis. Activation of P2Y2 receptor increases Cl- efflux and mucociliary clearance, effects that might relieve symptoms of cystic fibrosis. P2Y2 agonist therapy is tested in an attempt to bypass the dysfunctioning CFTR channel. Several P2Y2 receptor agonists, especially INS37217, being evaluated as possible targets for the treatment of cystic fibrosis.6


 



詢價 / 洽詢此產品

回到產品列表

▲ LINE
諮詢